Johnson & Johnson (JNJ)

Accumulated OCI

-$13.77B

Quarterly · Period ending: · USD

JNJ logo

JNJ Accumulated OCI

Latest reported-$13.77B
JNJ Quarterly Accumulated OCI ($0.00 → -$13.77B)
High-resolution chart · PNG

JNJ accumulated oci history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Johnson & Johnson Accumulated OCI — Quarterly (USD)
Period endingAccumulated OCI (USD)
-13,765,000,000
-13,951,000,000
-14,831,000,000
-14,930,000,000
-15,237,000,000
-14,305,000,000
-11,740,000,000
-11,741,000,000
-12,522,000,000
-11,253,000,000
-10,768,000,000
-12,527,000,000
-8,780,000,000
-13,135,000,000
-12,626,000,000
-12,967,000,000
-15,292,000,000
-13,843,000,000
-13,757,000,000
-13,058,000,000
-15,415,000,000
-15,100,000,000
-15,328,000,000
-15,242,000,000
-14,938,000,000
-15,533,000,000
-16,243,000,000
-15,891,000,000
-15,533,000,000
-14,969,000,000
-15,517,000,000
-15,222,000,000
-14,647,000,000
-14,777,000,000
-12,608,000,000
-13,199,000,000
-12,747,000,000
-13,234,000,000
-14,522,000,000
-14,901,000,000
-12,715,000,000
-12,707,000,000
-12,391,000,000
-13,165,000,000
-12,861,000,000
-12,054,000,000
-13,300,000,000
-10,722,000,000
-5,382,000,000
-3,007,000,000
-2,645,000,000
-2,860,000,000
-5,346,000,000
-6,810,000,000
-6,689,000,000
-5,810,000,000
-4,925,000,000
-6,204,000,000
-4,540,000,000
-5,632,000,000
-3,068,000,000
-1,192,000,000
-2,020,000,000
-3,531,000,000
-2,924,000,000
-5,705,000,000
-3,837,000,000
-3,058,000,000
-2,661,000,000
-4,481,000,000
-5,169,000,000
-4,955,000,000
-930,000,000
561,000,000
509,000,000
-693,000,000
-1,534,000,000
-1,898,000,000
-2,124,000,000
-2,118,000,000
-539,000,000
-550,000,000
-633,000,000
-755,000,000
-751,000,000
-805,000,000
-648,000,000
-526,000,000
-502,000,000
-537,000,000
-609,000,000
-608,000,000
-746,000,000
-708,000,000
-836,000,000
-867,000,000
-739,000,000
-671,000,000
-668,000,000
-560,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.